IP Library Granted Patent US 8,750,967
Granted Patent B2
US 8,750,967 · App. 13/260,578 · Granted Jun 10, 2014

Medical fluid delivery system with RFID-equipped wand

Inventors: John K. Bruce (Burlington, KY); Chad M. Gibson (Westerville, OH); Geoffrey S. Strobl (Williamsburg, OH)
Assignee: Mallinckrodt LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,750,967
App. No.
13/260,578
Granted
Jun 10, 2014
Kind
B2
Abstract

An injection device ( 120 ) used in delivering medical fluids to a patient is provided. The injection device ( 120 ) may include a syringe plunger driver ( 126 a ) and a syringe ( 140 ). The syringe ( 140 ) may include a syringe data storage device ( 134 ). The injection device ( 120 ) may include a communication device ( 132 a ) disposable in each of attached and detached conditions. The communication device ( 132 a ) may be operable to read a data storage device ( 134 ) within its field of view. When the communication device ( 132 a ) is attached to the injection device ( 120 ) and the syringe ( 140 ) is installed on the injection device ( 120 ), the communication device ( 132 a ) may be operable to read the data storage device ( 134 ) associated with the syringe ( 140 ). When in a detached condition, the communication device ( 132 a ) may be operable to be hand manipulated such that various other data storage devices ( 134 ) may be read.

Claims (19)

1. A method of operation of a medical fluid delivery system, said method comprising:

reading a first data storage device with a communication device, wherein said reading step comprises hand-maneuvering said communication device proximate to said first data storage device and relative to an injection device;

attaching said communication device to said injection device after said reading a first data storage device step;

installing a syringe on said injection device after said attaching step, wherein said syringe comprises a syringe data storage device; and

reading said syringe data storage device with said communication device while said syringe is installed on said injection device and while said communication device is attached to said injection device.

2. The method of claim 1 , wherein said first data storage device is attached to a patient and said reading a first data storage device step comprises moving said communication device proximate to said patient.

3. The method of claim 1 , further comprising detaching said communication device from said injection device prior to said reading a first data storage device step.

4. The method of claim 1 , further comprising reading a tubing set data storage device with said communication device.

5. The method of claim 4 , further comprising setting a pressure limit based on data read during said reading a tubing set data storage device step.

6. The method of claim 1 , further comprising storing data, in said communication device, acquired during said reading a first data storage device step prior to said attaching step.

7. The method of claim 1 , further comprising recharging a battery of said communication device while said communication device is attached to said injection device.

8. The method of claim 1 , further comprising verifying medical fluid from said syringe is appropriate for injection into a patient, wherein said verifying step takes into account data read from said first data storage device and said syringe data storage device.

9. The method of claim 1 , further comprising wirelessly transferring data from said communication device to said injection device.

10. The method of claim 1 , wherein said attaching step comprises interconnecting said communication device to said injection device via at least one conductive pathway.

11. The method of claim 1 , further comprising transferring data from said communication device to said injection device while said communication device is attached to said injection device.

12. The method of claim 1 , further comprising reading an operator data storage device with said communication device.

13. The method of claim 12 , wherein said reading an operator data storage device step comprises downloading an injection protocol from said operator data storage device to said communication device.

14. The method of claim 13 , further comprising executing said injection protocol to discharge medical fluid from said syringe.

15. The method of claim 12 , further comprising selecting an injection protocol from a plurality of injection protocols resident in said injection device based at least in part on data obtained from said operator data storage device.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2011
From: BRUCE, JOHN K.; GIBSON, CHAD M.; STROBL, GEOFFREY S.
To: MALLINCKRODT INC.
Reel/Frame 026972/0065 →
CHANGE OF LEGAL ENTITY Recorded Sep 27, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026978/0176 →
Continuity (2)
Provisional Application 61168003 · Apr 9, 2009
Related Publication 20120029349A1 · Feb 2, 2012